MARMITE maker Unilever yesterday defended its £50billion bid for GlaxoSmithKline’s consumer healthcare arm as the megabucks swoop triggered a slump in its share price.
Daily Express :: City and Business Feed
Unilever shares fall after £50bn GSK bid is rejected
